chr17-82082054-C-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_004104.5(FASN):c.6118G>T(p.Ala2040Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000414 in 1,610,508 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_004104.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FASN | NM_004104.5 | c.6118G>T | p.Ala2040Ser | missense_variant | 36/43 | ENST00000306749.4 | NP_004095.4 | |
FASN | XM_011523538.3 | c.6118G>T | p.Ala2040Ser | missense_variant | 36/43 | XP_011521840.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FASN | ENST00000306749.4 | c.6118G>T | p.Ala2040Ser | missense_variant | 36/43 | 1 | NM_004104.5 | ENSP00000304592 | P1 | |
FASN | ENST00000634990.1 | c.6112G>T | p.Ala2038Ser | missense_variant | 36/43 | 5 | ENSP00000488964 |
Frequencies
GnomAD3 genomes AF: 0.00223 AC: 340AN: 152136Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.000504 AC: 125AN: 248044Hom.: 1 AF XY: 0.000467 AC XY: 63AN XY: 134790
GnomAD4 exome AF: 0.000222 AC: 324AN: 1458254Hom.: 1 Cov.: 38 AF XY: 0.000186 AC XY: 135AN XY: 725520
GnomAD4 genome AF: 0.00225 AC: 342AN: 152254Hom.: 2 Cov.: 33 AF XY: 0.00216 AC XY: 161AN XY: 74454
ClinVar
Submissions by phenotype
FASN-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 19, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Epileptic encephalopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at